Dysfunction of dopaminergic receptor signaling in the brain is a hallmark of a number of neurodegenerative pathologies. Of the five dopamine receptors, the D3 subtype has emerged as a promising target for treating neurodegenerative diseases, especially Parkinson’s disease, due to the specific distribution of this receptor in limbic and nigrostriatal brain regions known to be associated with motor functions. Not only have D 3-selective agonists shown positive effects in re-establishing control of motor activity in animals, but they also display neuroprotective activity and may be important in reducing the dyskinesia side-effect often seen with current non-selective dopaminergic therapies. Herein we report the extension of our previous studies of racemic 3-hydroxyphenyl pyrrolidines to their chiral analogues. We have used our best racemic D3 ligand, N-nonyl-3-hydroxyphenyl pyrrolidine 74 (Ki = 13 nM), as starting point. Synthesis, characterization and D3 receptor affinity of both the R- and S-enantiomer of 74 will be reported. In addition, we will describe SAR studies of new chiral N-functionalized-3-hydroxyphenylpyrrolidines (based upon the steric requirements of compound 74 in which the N-substituent has been designed to engage key residues in the secondary binding site of the D3 receptor to enhance affinity and selectivity.
|Advisor:||Neumann, William L.|
|Commitee:||Crider, Michael A., Lu, Yun|
|School:||Southern Illinois University at Edwardsville|
|School Location:||United States -- Illinois|
|Source:||MAI 57/01M(E), Masters Abstracts International|
|Subjects:||Chemistry, Organic chemistry|
|Keywords:||Dopamine D3, Medicinal chemistry, Parkinson's disease|
Copyright in each Dissertation and Thesis is retained by the author. All Rights Reserved
The supplemental file or files you are about to download were provided to ProQuest by the author as part of a
dissertation or thesis. The supplemental files are provided "AS IS" without warranty. ProQuest is not responsible for the
content, format or impact on the supplemental file(s) on our system. in some cases, the file type may be unknown or
may be a .exe file. We recommend caution as you open such files.
Copyright of the original materials contained in the supplemental file is retained by the author and your access to the
supplemental files is subject to the ProQuest Terms and Conditions of use.
Depending on the size of the file(s) you are downloading, the system may take some time to download them. Please be